Overview

Novel Compositions for Treating or Preventing Dermal Disorders

Status:
Completed
Trial end date:
2017-11-30
Target enrollment:
Participant gender:
Summary
This trial examines the impact of a topical formulation of rapamycin on dermal thickness and senescence.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Drexel University
Treatments:
Everolimus
Sirolimus